Category: Biopharma

Brazil – General Provisions for Stability Studies of Active Pharmaceuticals and Medicines

February 26, 2020
Biopharma

ANVISA published the Resolution RDC 318/2019, which details about the criteria for carrying out stability studies of active pharmaceutical ingredients (IFAs), and of new, innovative, generic, similar,...

Regulatory Intelligence (RI) Unbolts all your Regulatory Challenges

July 12, 2019
Biopharma

Drug development has become highly complex than ever before since the globalization of the life sciences industry. Regulatory Intelligence (RI), which emerged about 15 years ago, is comparatively a...